Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-28 Exercise | 2023-03-01 4:55 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 43,082 | $0 | 104,350 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-01 4:55 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 11,813 | $2.17 | 104,350 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 5:04 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 373,470 | $0 | 373,470 (Direct) | View |
| 2022-02-28 Exercise | 2022-02-28 7:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 30,128 | $0 | 47,273 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-02-28 7:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 8,261 | $2.85 | 47,273 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:09 pm | N/A 2032-02-10 | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 275,560 | $0 | 275,560 (Direct) | View |
Ownership | 2021-10-29 4:18 pm | N/A 2025-02-05 | LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer | 0 | $0 | 241,082 (Direct) | View |